DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Type 1 Diabetes Pipeline Highlights - 2016 Update" drug pipelines to their offering.
Type 1 Diabetes Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Type 1 Diabetes market. It covers emerging therapies for Type 1 Diabetes in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Type 1 Diabetes pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Type 1 Diabetes pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Type 1 Diabetes pipeline products by the company.
Short-term Launch Highlights:
Find out which Type 1 Diabetes pipeline products will be launched in the US and Ex-US till 2019.
Key Topics Covered:
1. Type 1 Diabetes Pipeline by Stages
2. Type 1 Diabetes Pipeline by Drug Class
3. Type 1 Diabetes Pipeline by Company
4. Type 1 Diabetes Phase 3 Clinical Trial Insights
5. Type 1 Diabetes Phase 2 Clinical Trial Insights
6. Type 1 Diabetes Phase 1 Clinical Trial Insights
7. Type 1 Diabetes Preclinical Research Insights
8. Type 1 Diabetes Discovery Stage Insights
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/7nt8wm/type_1_diabetes